scholarly article | Q13442814 |
P356 | DOI | 10.1378/CHEST.123.1.174 |
P698 | PubMed publication ID | 12527619 |
P50 | author | Jordi Rello | Q37370747 |
Maria Bodí | Q70678722 | ||
P2093 | author name string | Emili Diaz | |
Miguel Gallego | |||
Marta Navarro | |||
Dolors Mariscal | |||
Jordi Valles | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pneumonia | Q12192 |
P304 | page(s) | 174-180 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Chest | Q5093377 |
P1476 | title | Microbiological testing and outcome of patients with severe community-acquired pneumonia | |
P478 | volume | 123 |
Q61864376 | Q61864376 |
Q61797266 | A case report of community-acquired Pseudomonas aeruginosa pneumonia complicated with MODS in a previously healthy patient and related literature review |
Q30399952 | Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection |
Q39051283 | Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy. |
Q36056874 | Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy |
Q57237831 | Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia |
Q61864365 | Comment évaluer, orienter et suivre un patient ayant une pneumonie aiguë communautaire ? Une exacerbation de bronchopneumopathie chronique obstructive ? |
Q37696804 | Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. |
Q51719782 | Community-acquired lobar pneumonia caused by Pseudomonas aeruginosa infection in Japan: a case report with histological and immunohistochemical examination. |
Q33822603 | Comparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumonia |
Q36688955 | Current clinical management of Legionnaires' disease |
Q21195015 | Demographics, guidelines, and clinical experience in severe community-acquired pneumonia |
Q37755008 | Diagnosis of community-acquired pneumonia in adults |
Q42219508 | Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia. |
Q35544707 | Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study |
Q44506906 | Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia |
Q34593229 | Etiology and outcome of severe community acquired pneumonia in immunocompetent adults |
Q55472226 | Evaluation of the Quality of Care among Hospitalized Adult Patients with Community-Acquired Pneumonia in Korea. |
Q28249185 | Guidelines for the management of adult lower respiratory tract infections--full version |
Q46076297 | Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit |
Q54977074 | How to manage Pseudomonas aeruginosa infections. |
Q52912099 | Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. |
Q47766508 | Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction |
Q45221743 | Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration |
Q37153323 | Linking joint commission inpatient core measures and national patient safety goals with evidence |
Q48002821 | Management of community-acquired pneumonia in persons with spinal cord injury. |
Q35917265 | Management of respiratory infections in the elderly |
Q28069467 | Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns |
Q43596478 | Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. |
Q36514914 | Optimal therapy for severe pneumococcal community-acquired pneumonia |
Q58706621 | Physicians' utilization of microbiologic reports and determinants of their preference to order culture in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia |
Q41976368 | Pneumonia in adults: the practical emergency department perspective |
Q34928386 | Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia. |
Q34683959 | Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia. |
Q38900979 | Severe pneumococcal community-acquired pneumonia admitted to medical Tunisian ICU. |
Q38181699 | Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia |
Q82556263 | The changing pathogens of complicated parapneumonic effusions or empyemas in a medical intensive care unit |
Q38067619 | The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. |
Q34626378 | Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam |
Q36062027 | Treatment of Legionnaires' disease |
Q40823340 | Use of Tracheal Aspirate Culture in Newly Intubated Patients with Community-Onset Pneumonia |
Q37022437 | Validation of a prediction rule for prognosis of severe community-acquired pneumonia |
Q37046209 | Value of RVP in clinical settings: intensive care |
Q79344025 | [Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections] |
Q79340135 | [Managing lower respiratory tract infections in immunocompetent patients. Definitions, epidemiology, and diagnostic features] |
Q91910734 | [Which samples to obtain in the emergency department for the microbiological diagnosis of community-acquired pneumonia in the immunocompetent patient?] |
Search more.